In Reply to 'Multiple-Biomarker Panel Estimated GFR Is Not Optimal or Cost-Effective' and 'Comparing Multiple-Biomarker Panels for Estimating GFR With Estimating Equations Without a Coefficient Distinguishing Black Individuals From Persons of Other Groups'.